Discovery of 1532-97-4

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.Recommanded Product: 1532-97-4, you can also check out more blogs about1532-97-4

Chemistry is an experimental science, and the best way to enjoy it and learn about it is performing experiments. Recommanded Product: 1532-97-4. Introducing a new discovery about 1532-97-4, Name is 4-Bromoisoquinoline

Tau prions feature in the brains of patients suffering from Alzheimer’s disease and other tauopathies. For the development of therapeutics that target the replication of tau prions, a high-content, fluorescence-based cell assay was developed. Using this high-content phenotypic screen for nascent tau prion formation, a 4-piperazine isoquinoline compound (1) was identified as a hit with an EC50 value of 390 nM and 0.04 Kp,uu. Analogs were synthesized using a hypothesis-based approach to improve potency and in vivo brain penetration resulting in compound 25 (EC50 = 15 nM; Kp,uu = 0.63). We investigated the mechanism of action of this series and found that a small set of active compounds were also CDK8 inhibitors.

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.Recommanded Product: 1532-97-4, you can also check out more blogs about1532-97-4

Reference：
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem